Market Research Logo

Slovenia Pharmaceuticals and Healthcare Report Q2 2016

Slovenia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Krka's exposure to Eastern European markets will continue to act as a drag on revenue growth.

However, strong sales growth in Western Europe will mitigate the impact of revenue declines for the shortterm. We expect a continued focus on cost containment by European healthcare payers to moderate Krka'sgrowth outlook over the longer term, unless the company looks to geographically diversify its exposure.

Headline Expenditure Projections

Pharmaceuticals: EUR671mn (USD745mn) in 2015 to EUR645mn (USD690mn) in 2016; -3.9% inlocal currency terms and -7.3% in US dollar terms. Forecasts revised downwards compared to previousquarter.

Healthcare: EUR3.22bn (USD3.58bn) in 2015 to EUR3.25bn (USD3.48bn) in 2016; 0.9% in localcurrency terms and -2.8% in US dollar terms. Forecasts revised slightly downwards compared toprevious quarter.

BMI Risk/Reward Index

Slovenia scores 56.0 out of a total of 100 in our Pharmaceutical Risk/Reward Index for Q216, up to 9thplace from 11th place in the previous quarter. Slovenia scores above the average for the region, which is52.6.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Slovenia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Slovenia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Slovenia 2010-2015)
Table: Healthcare Personnel (Slovenia 2010-2015)
Table: Healthcare Activity (Slovenia 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Table: Multinational Market Activity
Generic Drugmakers
Company Profile
Krka
Lek (Novartis/Sandoz)
Demographic Forecast
Table: Population Headline Indicators (Slovenia 1990-2025)
Table: Key Population Ratios (Slovenia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Slovenia 1990-2025)
Table: Population By Age Group (Slovenia 1990-2025)
Table: Population By Age Group % (Slovenia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report